Can't wait to hear Maggie's view on the Medical Home? No problem, our next speaker is Arnold Milstein, who uses the
Health Affairs bully blogpit to distinguish between medical homes and
medical home runs. The DMCB thinks this makes for interesting not only because it has had its own
doubts, but because it views homes as 'process,' while runs are the 'outcomes.' As we've learned in other clinical domains, one doesn't necessarily lead to the other. Is the same true here?
Neil Versel of the
Healthcare IT Blog takes the dais and shows us just how
impolitic it is it is when politicians laughingly speak the honest truth. Rep. Pete Stark (D-CA) introduced legislation with some commonsense reforms, including an open source EHR, the promotion of de-identified data use, and clarification of HIPAA. Likelihood of passage? Zero. And those of us who have watched Congress deal with other parts of healthcare reform? We say welcome to the club.
But it’s a sad day when doctors fail to speak the truth. Say it’s not so, but Henry Stern of
InsureBlog alerts us to a
report that some British physicians may not be letting their patients know about the option of getting potentially life-saving treatment abroad. Egads. Maybe they should put their mis-speaking skills to use by coming across the pond, getting U.S. citizenship and running for Congress.
When it comes to politics, timing is everything. Well, the same is true when it comes to generic drug pricing in the Medicare program. Dr. Fein of
Drug Channels shows us how quarter-to-quarter delays in pricing and reimbursement can simultaneously harness the for-profit motive and increase the use of generic drugs. Too good to be true?
Not if the Department of Health and Human Services Office of the Inspector General gets its way.New America’s California branch members Leif Wellington Haase and Micah Weinberg take to the lecturn and dissect California’s
messy budget impasse and its impact on MediCal and the individual insurance market. If you believe the Golden State is still a window into the future and support State sponsored reforms, however, be of good cheer. According to this report, a budget will eventually be passed in the short term and Californians are more than ever supportive of meaningful reform and seem to be willing to pay for it over the long term.
And speaking of California (and the rest of states), Anthony Wright of the
Health Access Weblog examines the pros and cons of State reforms aimed at the individual insurance market. He points out the ‘
lipstick’ of guaranteed issue, risk pooling, consumer protections, basic benefit structures and tight regulation may not be enough, but he wonders if it isn’t worth a try. Take a read and see if you agree.
Never mind kissing babies, Roy Poses over at
Health Care Renewal calls both the American
College of Cardiology and
Johnson and Johnson awardees quoted in the Wall Street Journal to task for wanting to keep the bathwater
and the babies
AND the CME/research funding. Let's face facts, says he. Lingering K-street style conflicts of interest, both known and unknown, are influence-peddling physicians in obvious and subtle ways. He makes a good argument over the groupthink notion that transparency is enough. A case in point is when apologists for the status quo themselves aren’t being fully transparent. The DMCB suggests readers Google their own names before going public with a high profile opinion in the area of pharma support for CME.
Louise of the
Colorado Insurance Insider is angry at Pharma. Biased research. Underhanded marketing. Ghost writing. Predatory pricing. And now this:
our receptors are possibly being nudged in unforeseen ways by microscopic but potentially significant amounts of myriad drugs coming out of our faucets. She asks if the improper disposal of pharmaceuticals is the result of laziness and an unhealthy profit motive. Blister packs may help, but more importantly, Louise asks where the leadership of the health insurance industry is on this issue? When the DMCB takes his drugs, he’s going to wash them down with bottled water. And then recycle the plastic, naturally. And try not to feel guilty the next time he goes to the bathroom.
Are you a practicing physician and a blogger? Do you like that spotlight of a cheering audience’s attention? Sam Solomon at the
Canadian Medicine Blog reminds you that it may pay for you to be
scrupulously circumspect when it comes to writing about your patients, especially if there are allegations of negligence. You may think you can mask your identity or protect your patients’ privacy. Think again, because if this determined trial lawyer can find out who you are, chances are others can also. Right after they check out that
regrettably unprofessional profile on a social networking site.
Maybe instead of blogging, physicians (and other health policy experts) may want to make better use of their time by not only getting familiar with P4P, DM, PCMH, CDHPs and EHRs but with
MPs that are being championed by IHI. Click here to find out if this particular initiative will warrant its own set of initials, thanks to Joanne Kenen of the
New Health Dialogue Blog, also of the New America Foundation.
There are the new initiatives of course, but then there are the old ones that work. David Harlow of the
HealthBlawg reminds us that the CEO Leah Binder of the Leapfrog Group is still
reminding us that we have to start somewhere. That somewhere may be outcomes-based, like hospital acquired infections and multiple other remediable complications that can be addressed with a turnkey NQF-based methodology, maximum transparency and purchaser activism. Now that will warm any crowd.
And then there’s always a speaker that cuts through all the chatter with inconvenient truths. Merrill Goozner of
Gooznews reports on the
countervailing perspectives of a debate sponsored by the New America Foundation. In the end, we Americans will never yield on our death-is-optional pursuit of happiness, even if means taking a pill of dubious benefit or being tethered to a ventilator with cost effectiveness ratios well north of $100K per QALY.